Perle Bioscience
Atlanta · Founded 2013
About Perle Bioscience
Perle is setting the stage for usage of a new proprietary peptide therapy for generation of new insulin producing cells, which is a breakthrough with the potential to benefit millions of people.
Company Facts
- Founded: 2013
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Last round: Product Crowdfunding (Sep 2013)
- Website: perlebioscience.com
- Phone: (703) 568-4222
Social Profiles
Canonical: https://fsome.com/organization/perle-bioscience-8283449 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.